MicroAlgo announces quantum blockchain architecture with cyclic QSC and QKD
MicroAlgo Inc. (NASDAQ: MLGO) announced the development of a quantum blockchain architecture that incorporates cyclic quantum secure communication and quantum key distribution technologies to enhance transaction security and transparency.
The architecture features a four-layer design structure. The quantum communication layer implements cyclic QSC and QKD technologies to provide secure communication and key distribution for blockchain network nodes. The blockchain core layer maintains network stability using distributed ledger technology and quantum encryption for transaction data protection.
The smart contract layer provides an execution environment supporting user-defined transaction rules, incorporating quantum signature technology for contract security. The application layer serves as the interface for users to interact with the blockchain network and offers API interfaces for third-party developers.
According to the company's statement, the quantum key distribution technology ensures security in key generation and distribution, while quantum encryption protects transaction data against quantum computing threats. The system includes periodic key updating and rotation for long-term security maintenance.
The company acknowledged that the promotion and application of the architecture face challenges, noting that quantum technology maturity and commercialization require further development to support large-scale applications.
MicroAlgo, based in the Cayman Islands, develops central processing algorithms and provides solutions that integrate algorithms with software and hardware components. The company offers services including algorithm optimization, computing power acceleration, and data intelligence services.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crawford & Company names new Middle East director ahead of retirement
- Canton Strategic Holdings launches Canton Coin locking service
- Alps Group launches patient-derived organoid cancer program in Malaysia
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share